Tufts CSDD

Revisiting eClinical Technology Solutions Adoption

Sunday, February 15, 2015

Eight years after the introduction of the first eClinical technologies, many sponsors and CROs remain uncertain about their plans to adopt newer and less common technologies, while use of more established tools continues to grow. [Read More]

Balancing conducting patient recruitment with privacy

Tuesday, May 27, 2014

The Pulse on Patient Recruitment by Ashley Tointon

It takes an average of 12 years for a medicine to make it to market and, regardless of the molecule’s Fast Track or Breakthrough Therapy status, the medicine must make it through the rigors of clinical trials before it can be marketed and sold.

[Read More]

Drug developers use new models and methods to boost clinical success rates

Thursday, April 17, 2014

Drug companies and their development partners seeking to increase clinical trial success rates of new drug candidates are developing tools to help them predict the likelihood of marketing approval and incorporating business planning earlier in clinical development, according to R&D leaders who recently participated in a roundtable discussion convened by the Tufts Center for the Study of Drug Development (CSDD).

[Read More]

New Breakthrough Therapy Designation shows potential to shorten drug development time

Wednesday, January 29, 2014

The Breakthrough Therapy Designation (BTD) program, launched nearly 18 months ago by the FDA and aimed at expediting development and review of drugs intended to treat a serious condition, has the potential to shorten development time considerably, according to the Tufts Center for the Study of Drug Development (Tufts CSDD), which recently completed an assessment of the BTD program.

[Read More]